Dina Robaa
Impact in
- Geriatrics and Gerontology top 2%
- Sirtuins and Resveratrol in Medicine
- Physiology top 2%
Papers in
-
- Histone Deacetylase Inhibitors Research 34
- Protein Degradation and Inhibitors 18
- Epigenetics and DNA Methylation 10
- Ubiquitin and proteasome pathways 6
- Protein Structure and Dynamics 6
- Co-authors
- Wolfgang Sippl (61 shared papers)Manfred Jung (28 shared papers)Christophe Romier (18 shared papers)Matthias Schiedel (4 shared papers)Jelena Melesina (11 shared papers)Daniel Herp (7 shared papers)Raymond J. Pierce (8 shared papers)T.B. Shaik (7 shared papers)
In The Last Decade
Dina Robaa
74 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 94
- Geriatrics and Gerontology 127
- Physiology 126
- Molecular Biology 1.4k
- Oncology 454
- Parasitology 116
Countries citing papers authored by Dina Robaa
This map shows the geographic impact of Dina Robaa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dina Robaa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dina Robaa more than expected).
Fields of papers citing papers by Dina Robaa
This network shows the impact of papers produced by Dina Robaa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dina Robaa. The network helps show where Dina Robaa may publish in the future.
Co-authors
The 25 scholars most cited alongside Dina Robaa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 77 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 219 | |
| 2 | 2017 | 99 | |
| 3 | 2018 | 93 | |
| 4 | 2016 | 93 | |
| 5 | 2021 | 86 | |
| 6 | 2019 | 79 | |
| 7 | 2018 | 78 | |
| 8 | 2017 | 71 | |
| 9 | 2017 | 66 | |
| 10 | 2015 | 56 | |
| 11 | 2020 | 50 | |
| 12 | 2021 | 38 | |
| 13 | 2018 | 37 | |
| 14 | 2015 | 36 | |
| 15 | 2014 | 36 | |
| 16 | 2015 | 35 | |
| 17 | 2018 | 33 | |
| 18 | 2015 | 31 | |
| 19 | 2017 | 30 | |
| 20 | 2017 | 29 |
About Dina Robaa
Dina Robaa is a scholar working on Molecular Biology, Organic Chemistry, Oncology, Cellular and Molecular Neuroscience and Pharmacology, having authored 77 papers that have together received 2.0k indexed citations. Recurring topics across this work include Histone Deacetylase Inhibitors Research (34 papers), Protein Degradation and Inhibitors (18 papers), Peptidase Inhibition and Analysis (12 papers), Epigenetics and DNA Methylation (10 papers), Neuroscience and Neuropharmacology Research (9 papers), Cholinesterase and Neurodegenerative Diseases (7 papers), Ubiquitin and proteasome pathways (6 papers) and Protein Structure and Dynamics (6 papers). The work is most often cited by research in Geriatrics and Gerontology (127 citations), Physiology (126 citations), Molecular Biology (1.4k citations), Oncology (454 citations) and Parasitology (116 citations). Dina Robaa has collaborated with scholars based in Germany, France and Egypt. Frequent co-authors include Wolfgang Sippl, Manfred Jung, Christophe Romier, Matthias Schiedel, Jelena Melesina, Daniel Herp, Raymond J. Pierce, T.B. Shaik, Frank Erdmann and Matthias Schmidt. Their work appears in journals such as Journal of Medicinal Chemistry, European Journal of Medicinal Chemistry, ChemMedChem, International Journal of Molecular Sciences and Archiv der Pharmazie.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.